Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FREDERICK K ASARE

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1821195090
CMS profile
643078
Location
FAYETTEVILLE, NC

General Payments · PY2018–2024

$59,395.98

  • Reported across 131 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$28,068.41

20 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $27,939.96 12
Food and Beverage $128.45 8

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $27,939.96 12
Acerta Pharma LLC $30.77 2
Amgen Inc. $18.74 1
GlaxoSmithKline, LLC. $16.92 1
DEXCOM, INC. $16.51 1
Novo Nordisk AS $16.22 1
Lilly USA, LLC $15.03 1
Bayer HealthCare Pharmaceuticals Inc. $14.26 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $420.93 14
PY2019 $50.10 3
PY2020 $577.97 30
PY2021 $312.86 21
PY2022 $11,772.82 25
PY2023 $18,192.89 18
PY2024 $28,068.41 20

Payment records · PY2024 (20)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $18.74 10/23/2024 Food and Beverage Undisputed 01/23/2026 1117193031 CMS
AstraZeneca Pharmaceuticals LP $16.31 01/31/2024 Food and Beverage Undisputed 01/23/2026 1105709048 CMS
AstraZeneca Pharmaceuticals LP $14.46 07/11/2024 Food and Beverage Undisputed 01/23/2026 1105741638 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.26 09/26/2024 Food and Beverage Undisputed 01/23/2026 1086212143 CMS
Dexcom, Inc. $16.51 06/26/2024 Food and Beverage Undisputed 01/23/2026 1153300656 CMS
GlaxoSmithKline, LLC. $16.92 12/12/2024 Food and Beverage Undisputed 01/23/2026 1116191723 CMS
Lilly USA, LLC $15.03 11/07/2024 Food and Beverage Undisputed 01/23/2026 1134997596 CMS
Novo Nordisk Inc $16.22 05/09/2024 Food and Beverage Undisputed 01/23/2026 1097475365 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137474919 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137474923 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137474926 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,353.33 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137474930 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,353.33 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137474934 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,353.33 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137474938 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,353.33 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137474942 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,353.33 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137474946 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,353.33 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137474950 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,353.33 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137474954 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,353.33 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137474957 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,353.33 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137474961 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.